VLA 0.00% $1.75 viralytics limited

$30m expected raising, page-4

  1. 1,578 Posts.
    lightbulb Created with Sketch. 105
    Because they now have the funds to run multiple phase three trials and don't need to partner with big pharma. Big pharma now need us more than we need them.

    The last time a CR was held we lost more than a QTR of the company however the SP tripled in the following months. Hang in there.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.